Tokushima University Hospital has established the Tokushima Network for Clinical Trials (TNCT) to promote clinical trials in the area in collaboration with the Tokushima Medical Association. The present study investigated the views of doctors towards registration trials in the TNCT. A questionnaire was provided to 49 clinics/hospitals registered to the TNCT in 2006 and 38 (78%) responded. It revealed that 48% of doctors were aware of registration trials and 87% were favourable towards participating as investigators in them. They considered close contact with developmental drugs, advancement of therapy and the opportunity to learn about state-of-the-art treatment as benefits of participation. The main areas of difficulty included management of adverse reactions and patients' refusal to take part. Many doctors wanted more opportunity to learn about trial-related issues such as regulations. The survey indicates that the TNCT needs to develop the infrastructure and enlighten participants to promote registration trials in this rural regional area.
The Views of Doctors on Registration Trials in a Japanese Rural Area: a Survey of Medical Institutions Registered to the Tokushima Network for Clinical Trials Introduction Clinical trials play a central role in various phases of the drug development process. Since the introduction in Japan of the Good Clinical Practice (GCP) standard in 1997, approved by the International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH), 1 the Japanese infrastructure for clinical trials leading to drug approval (registration trials) has developed. Previously, most registration trials in Japan were carried out in academic and public hospitals, but there is a recent trend towards clinics and private hospitals also playing a role in registration trials. 2 Most clinics cannot meet the requirements of the GCP guidelines, such as oversight by an 
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institutional review board or management of severe adverse events. The establishment of a national and regional network for clinical trials among medical institutions was, therefore, emphasized in the plan for promoting registration trials by the Ministry of Health, Labor and Welfare and the Ministry of Culture and Science of Japan. This is now spreading as a means of effectively overcoming these issues and promoting clinical trials. At Tokushima University Hospital, an academic hospital in the Shikoku district of Japan, the Clinical Trial Centre for Developmental Therapeutics was set up in 1999 to support clinical trials. 3 In 2004, in order to spread information on this supporting system in the regional area, Tokushima University Hospital, in collaboration with the Tokushima Medical Association, set up the Tokushima Network for Clinical Trials (TNCT) which comprises regional medical institutions. Gaining a clearer understanding of the attitudes of doctors towards clinical trials may help in progressing the support for clinical trials that is provided by the TNCT in this rural area of Japan. Questionnaires were, therefore, developed to survey the attitudes of those doctors registered in the TNCT towards registration trials, and this paper presents the results of these investigations and suggests the next steps that might be taken.
Subjects and methods

THE QUESTIONNAIRE
This research is based on the same questionnaire that was previously used in studies on doctors' views of registration trials at Tokushima University Hospital which were conducted in 2000 and 2004. 4 The questionnaire started by examining general attitudes towards registration trials on a four-point scale (strongly agree, agree, disagree and strongly disagree). This was followed by practical questions, such as the benefits to doctors of involvement in registration trials and the difficulties regarding participation as investigators. In addition, there was an opportunity for doctors to add more details to their responses if they desired. The questionnaire was provided to each medical institution registered to the TNCT in 2006. One representative from each institution was asked to participate.
STATISTICAL ANALYSIS
In view of the small number of subjects included in this study, no statistical analysis of the data was performed. The results have been used to improve the activities of the TNCT and to provide information for the development of future studies.
Results
RESPONDENT CHARACTERISTICS
Responses were received from 38 out of 49 institutions (78%). Among those responding, only six institutions (16%) were currently contributing and/or had previously contributed to registration trials after 1997, the year that the GCP standard was implemented in Japan. Nevertheless, 26 doctors (68%) who responded to the survey had contributed to registration trials on an individual level at previous institutions.
GENERAL ATTITUDE TOWARDS REGISTRATION TRIALS
When questioned about clinical trials, 48% of the doctors stated that they were familiar with clinical trials and the drug approval process ( Fig. 1A) and 87% of the doctors gave favourable responses when asked about their attitude towards participating as investigators in registration trials ( Fig. 1B ).
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BENEFITS OF PARTICIPATING AS INVESTIGATORS IN REGISTRATION TRIALS
Selected answers from the 38 respondents are shown in Fig. 2A . The number and percentage that responded to each possible benefit of participation were as follows: close contact with developmental drugs (20, 53%), advancement of therapy (19, 50%), the chance to be made aware of state-of-the-art treatment (18, 47%), therapeutic options (15, 39%), contact with clinical trial methodology (11, 29%), financial benefits for the hospital (8, 21%), and improvement in confidence among patients (5, 13%). One doctor commented that 'collaboration in this kind of network organized by Tokushima University Hospital itself is a chance for occupational training'.
DIFFICULTIES FOR INVESTIGATORS PARTICIPATING IN REGISTRATION TRIALS
Selected answers from the 38 respondents are shown in Fig. 2B . The number and percentage that responded in terms of perceived difficulties were as follows: management and reporting of adverse events (17, 45%), patients' refusal to take part (16, 42%), cumbersome procedures (15, 39%), contract-related processes (12, 32%), lack of time (11, 29%), anxiety in the consultation system when some questions arise (7, 18%) and the informed consent process (4, 11%). 
TRAINING NEEDS
Discussion
Investigators participating in Japanese registration trials used to undertake virtually every task, from patient care to administrative work, during the course of a clinical study. 5 Since the introduction of the CRC concept, investigator workload reduction seems to have been achieved. Nevertheless, our previous studies revealed that doctors' views regarding registration trials at Tokushima University Hospital have remained conventional. 4 A clear understanding of the attitude of doctors at networking medical institutions, therefore, may contribute to the establishment of an effective network strategy, and improve the understanding and organization of clinical trials in regional areas. The present survey revealed that 48% of the doctors questioned were familiar with registration trials and their attitude towards participating as investigators in these trials was favourable (87% felt positive). In our previous studies that were conducted in 2000 and 2004 at Tokushima University Hospital, we reported that more doctors were familiar with registration trials (66% in 2004 and 84% in 2000) but fewer felt favourable towards participating as investigators (58% in 2004 and in 66% in 2000). 4 Considering that the doctors who responded to the 
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present survey seem to be more naive regarding registration trials than those who replied to the previous survey, the widespread belief that involvement in registration trials is an essentially complicated process might be responsible for the less favourable attitude of the previous respondents.
Since the doctors voluntarily registered in the TNCT, almost all who responded to the present survey seemed to have a general interest in clinical research and registration trials. The benefits of contact with developmental drugs, advancement of therapy and the chance to learn about stateof-the-art treatment were major incentives for participation as investigators in registration trials. In the previous studies of doctors' at Tokushima University Hospital, 4 the major benefits were close contact with developmental drugs, advancement of therapy and financial benefits for the hospital. A study of doctors in Finland reported that financial incentives, the possibility of incorporating a personal substudy or other benefits for personal research, and scientific and clinical interest in the trial were the primary motivating factors. 6 In addition, the ability to carry out studies in practice and the opportunity to participate in a trial whilst undertaking postgraduate specialist education were also considered to be beneficial. These results show that doctors have a positive attitude overall towards registration trials as an opportunity for education.
Doctors, as clinical trial investigators, must have sufficient time and qualified staff to conduct trials properly. Implementation of a trial often involves various practical difficulties that may be overcome through networking.
In the present study, management and reporting of adverse events, patients' refusal to take part and cumbersome procedures were the main difficulties perceived by investigators participating in registration trials. In the studies conducted previously at Tokushima University Hospital, 4 the main difficulties were patients' refusal, the informed consent process and cumbersome procedures. These differences may reflect the fact that doctors in the TNCT have fewer resources for the management of severe adverse events. In an investigation of doctors in the Tsugaru area of Aomori Prefecture, Japan, Ohkubo et al. 7 reported that patient recruitment, adherence to protocols and cumbersome procedures were the main negative factors towards participation in registration trials. It seems that obtaining the consent of study participants is a common problem in registration trials, and the lack of volunteer spirit and, more importantly, the lack of benefits from participation, are reasons often mentioned for the strong resistance among the Japanese population to be subjects in clinical trials. 5 Hospital. In addition, several seminars involving clinical trial specialists have taken place annually since 2004. Since about half the doctors had never attended any of these seminars, further enlightenment is warranted and future seminars should focus on the areas revealed by this study to be of benefit to doctors registered in the TNCT.
In conclusion, this survey revealed that even in a rural area of Japan, many doctors had favourable attitudes toward participation in registration trials. In the USA, academic medical centres have established specific research centres to promote and provide better conditions for clinical research. 8 In Japan, it is necessary to develop the infrastructure in regional areas based on the information obtained in the present study.
